Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 604

[263] Janes KA, Alonso MJ. Depolymerized chitosan nanoparticles for protein delivery: prep-
aration and characterization. J Appl Polym Sci 2003;88:2769-76.
[264] Zhang XG, Teng DY, Wu ZM, Wang X, Wang Z, Yu DM, et al. PEG-grafted chitosan
nanoparticles as an injectable carrier for sustained protein release. J Mater Sci Mater
Med 2008;19:25-33.
[265] Jiang J, Bischof J. Effect of timing, dose and interstitial versus nanoparticle delivery of
tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3
uterine fibroid tumor. Cryo Letters 2010;31:50-62.
[266] Quellec P, Gref R, Perrin L, Dellacherie E, Sommer F, Verbavatz JM, et al. Protein
encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical char-
acterization. J Biomed Mater Res 1998;42:45-54.
[267] Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharma-
ceutical applications. Adv Drug Delivery Rev 2003;55:403-19.
[268] Zhang Y, Zhuo R. Synthesis and in vitro drug release behavior of amphiphilic tri-
block copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone.
Biomaterial 2005;26:6736-42.
[269] Li JK, Wang N, Wu XS. Poly (vinyl alcohol) nanoparticles prepared by freezing-
thawing process for protein/peptide drug delivery. J Control Release 1998;56:117-26.
[270] Langer R. Drug delivery and targeting. Nature 1998;392(Suppl):5-10.
[271] Zhang K, Wu XY. Temperature and pH-responsive polymeric composite membranes for
controlled delivery of proteins and peptides. Biomaterials 2004;25:5281-91.
[272] Hoffman AS. Intelligent, polymers. In: Park K, editor. Controlled drug delivery chal-
lenges and strategies. Washington, DC: ACS; 1997. p. 485-98.
[273] Qiu Y, Park K. Environment-responsive hydrogels for drug delivery. Adv Drug Delivery
Rev 2001;53:321-39.
[274] Sawant RM, Hurley JP, Salmaso S, Kale A, Tolcheva E, Levchenko TS, et al. “SMART”
drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
Bioconjug Chem 2006;17:943-49.
[275] Cui Z, Mumper RJ. Coating of cationized protein on engineered nanoparticles results in
enhanced immune responses. Int J Pharm 2002;238:229-39.
[276] Cui Z, Patel J, Tuzova M, Ray P, Phillips R, Woodward JG, et al. Strong T cell type-1
immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. Vaccine 2004;22:
2631-40.
[277] Piras AM, Chiellini F, Fiumi C, Bartoli C, Chiellini E, Fiorentino B, et al. A new bio-
compatible nanoparticle delivery system for the release of fibrinolytic drugs. Int J Pharm
2008;357:260-71.
[278] Golub JS, Kim YT, Duvall CL, Bellamkonda RV, Gupta D, Lin AS, et al. Sustained
VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart
Circulatory Physiol 2010;298:1959-65.
[279] Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C. Preparation and char-
acterization of protein C-loaded PLA nanoparticles. J Control Release 1999;60:
179-88.
[280] Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J
Pharm Biopharm 2009;71:161-72.
[281] Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug deliv-
ery. Adv Drug Delivery Rev 2004;56:1257-72.
[282] Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured
lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Delivery
Rev 2002;54:S131-55.